studies investigating its effectiveness alongside other canker sore treatments were still needed. Because it is an inhibitor of the protein kinases TBK1 and IKK-ε, which are implicated in the etiology of type II diabetes and obesity, amlexanox may be a candidate for human clinical trials testing in relation to these diseases. Synthesis References Anti-inflammatory agents Leukotriene antagonists Carboxylic acids Isopropyl compounds